India launches vaccination campaign against Kovid-19. Vaccination

India launches vaccination campaign against Kovid-19.  Vaccination

a India This Saturday (16) began its vaccination campaign to control the new coronavirus epidemic. Sanitary worker Manish Kumar was the first person to receive covaxin vaccine supplements from the Indian pharmaceutical company Bharat Biotech. The country will give priority to nurses, doctors and other frontline workers at the beginning of vaccination.

Kumar received his dose at the Indian Institute of Medical Sciences (AIIMS), one of the 3,006 vaccination centers set up across the country.

Indian Prime Minister Narendra Modi held a video conference with health professionals and, with tears in his eyes, kicked off the Indian immunization scheme.

Modi said, “The disease separated people from their families, kept mothers away from their children and those who died of the disease were not able to say a final goodbye to their family.”

The 70-year-old Modi did not say if he would get the vaccine, but said that politicians would not be considered a priority at the beginning of the vaccination campaign.

On the first day of the vaccination campaign, which the government says is the largest in the world, there are plans to vaccinate more than 300 million people in India.

With a population of about 1.4 billion people, India is the second most populous country in the world, behind only China. The government says it will not have the vaccine to receive mass vaccination.

The first line for the vaccine will be on the Kovid Line of Action to healthcare professionals and other activists. In this group, there are about 30 million people. After them, people from the sanitation and security sector will come.

Finally, the first part of the vaccination campaign aims to immunize 270 or more than 50 million people believed to be at high risk due to existing medical conditions.

In addition to the Bharat Biotech vaccine, India also produces Oxford University in partnership with pharmaceutical company AstraZeneca. However, the population will not be able to choose which immunizer to take. The effectiveness of kovaxine is still unknown. Oxford vaccine According to researchers, 70% effectiveness is.

Brazil has an agreement to import the Oxford vaccine from India. The aircraft, which will receive two million doses, however, Will leave the country in only 2 or 3 daysAccording to the president Jair Bolsonaro.

The Indian government says it has 11 million doses of the Oxford vaccine ready to be applied and 5.5 million from Kovaxin.

Second country in number of cases and deaths

India, after which the number of cases of coronavirus is highest Us, Plans to vaccinate around 300 million people in the first eight months of this year.

About 10.5 million people have been infected with coronovirus from India, of which more than 152,000 have died. Johns Hopkins University.

Agreement with Brazilian Company

Indian medicine india biotech On 12 January it was announced that it had signed an agreement to supply its vaccines against Kovid-19 Kovaxin for the Brazilian company Précis Medimentos.

The amount of vaccines available to Brazil has not been disclosed, but the priority of supply is to the public sector, through an agreement with the Brazilian government, if it expresses interest.

VIDEOS: know what is new about Kovid-19 vaccine

About the author: Cory Weinberg

"Student. Subtly charming organizer. Certified music advocate. Writer. Lifelong troublemaker. Twitter lover."

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *